U.S. Markets close in 23 mins.

Adamis Pharmaceuticals Corporation (ADMP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.225+0.025 (+0.481%)
As of 3:34PM EDT. Market open.
People also watch
OCULTNXPACRXAUPHADMS
Full screen
Previous Close5.200
Open5.250
Bid5.200 x 2000
Ask5.250 x 1700
Day's Range5.100 - 5.330
52 Week Range2.400 - 6.450
Volume368,226
Avg. Volume598,481
Market Cap163.81M
Beta0.72
PE Ratio (TTM)-6.01
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube3 days ago

    ETFs with exposure to Adamis Pharmaceuticals Corp. : September 18, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Adamis Pharmaceuticals Corp. Here are 5 ETFs with the largest exposure to ADMP-US. Comparing the performance and risk of Adamis Pharmaceuticals Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube14 days ago

    ETFs with exposure to Adamis Pharmaceuticals Corp. : September 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Adamis Pharmaceuticals Corp. Here are 5 ETFs with the largest exposure to ADMP-US. Comparing the performance and risk of Adamis Pharmaceuticals Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Adamis Pharmaceuticals Corp. :ADMP-US: Earnings Analysis: Q2, 2017 By the Numbers : September 6, 2017
    Capital Cube15 days ago

    Adamis Pharmaceuticals Corp. :ADMP-US: Earnings Analysis: Q2, 2017 By the Numbers : September 6, 2017

    Categories: Yahoo FinanceGet free summary analysis Adamis Pharmaceuticals Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Adamis Pharmaceuticals Corp. – Corcept Therapeutics Incorporated., Pernix Therapeutics Holdings, Inc., Antares Pharma, Inc., Pfizer Inc., Johnson & Johnson, Mylan N.V., GlaxoSmithKline plc Sponsored ADR and Teva Pharmaceutical ... Read more (Read more...)